All-cause mortality and cardiovascular safety of basal insulin treatment in patients with type 2 diabetes mellitus: A systematic review with meta-analysis and trial sequential analysis-Reference-Cited by-同舟云学术

All-cause mortality and cardiovascular safety of basal insulin treatment in patients with type 2 diabetes mellitus: A systematic review with meta-analysis and trial sequential analysis

Published:2021-03 Issue: Volume:173 Page:108688
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Rados Dimitris Varvaki,Falcetta Mariana Rangel Ribeiro,Pinto Lana Catani,Leitão Cristiane Bauermann,Gross Jorge Luiz

Funder

Hospital de Clinicas de Porto Alegre

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference50 articles.

1. The past 200 years in diabetes;Polonsky;N Engl J Med,2012

2. The treatment of diabetes mellitus;Joslin;Can Med Assoc J,1916

3. Use of antidiabetic drugs in the U.S., 2003–2012;Hampp;Diabetes Care,2014

4. Effects of intensive glucose lowering in type 2 diabetes;Gerstein;N Engl J Med,2008

5. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes;Patel;N Engl J Med,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities;Diabetologia;2024-04-16

2. Efficacy and safety of basal insulins in people with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials;Frontiers in Endocrinology;2024-03-21

3. Stroke Prevention by Antihyperglycemic Drugs in Type 2 Diabetes Mellitus;Endocrine Practice;2023-12

4. Efficacy and safety of once‐weekly versus once‐daily basal insulin analogues in the treatment of type 2 diabetes mellitus: A systematic review and meta‐analysis;Diabetes, Obesity and Metabolism;2023-09-05

5. Reduced Acute Diabetes Events After FreeStyle Libre System Initiation in People 65 Years or Older with Type 2 Diabetes on Intensive Insulin Therapy in France;Diabetes Technology & Therapeutics;2023-06-01